tiprankstipranks
Trending News
More News >

Challenger Limited Acquires Substantial Stake in Integral Diagnostics

Story Highlights
  • Challenger Limited has acquired a 5.40% voting power in Integral Diagnostics.
  • This acquisition may influence Integral Diagnostics’ market dynamics and shareholder interests.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Challenger Limited Acquires Substantial Stake in Integral Diagnostics

Confident Investing Starts Here:

Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an update.

Challenger Limited has become a substantial holder in Integral Diagnostics Limited, acquiring a significant voting power of 5.40%. This acquisition reflects Challenger Limited’s strategic interest in Integral Diagnostics, potentially impacting the company’s market dynamics and shareholder interests.

More about Integral Diagnostics Ltd.

YTD Price Performance: -18.90%

Average Trading Volume: 1,437,565

Technical Sentiment Consensus Rating: Buy

Current Market Cap: A$877.5M

Learn more about IDX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1